Google Übersetzer
Bluejay Diagnostics Inc
About
Bluejay Diagnostics Inc (NASDAQ:BJDX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 7 2026
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
Mar 12 2026
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
Mar 6 2026
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook
Feb 20 2026
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised
Feb 17 2026
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026
Financials
Revenue
$0
Market Cap
$2.02 M
EPS
-15.25